1. Home
  2. VNCE vs RNTX Comparison

VNCE vs RNTX Comparison

Compare VNCE & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vince Holding Corp.

VNCE

Vince Holding Corp.

HOLD

Current Price

$2.98

Market Cap

32.8M

ML Signal

HOLD

RNTX

Rein Therapeutics Inc. Common Stock

HOLD

Current Price

$1.36

Market Cap

38.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VNCE
RNTX
Founded
2002
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.8M
38.9M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
VNCE
RNTX
Price
$2.98
$1.36
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$4.63
$10.00
AVG Volume (30 Days)
68.1K
236.7K
Earning Date
12-09-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$291,286,000.00
N/A
Revenue This Year
$1.48
N/A
Revenue Next Year
$4.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$1.04
52 Week High
$6.89
$3.50

Technical Indicators

Market Signals
Indicator
VNCE
RNTX
Relative Strength Index (RSI) 61.72 46.39
Support Level $2.31 $1.15
Resistance Level $2.79 $1.58
Average True Range (ATR) 0.18 0.11
MACD 0.06 -0.01
Stochastic Oscillator 98.12 48.84

Price Performance

Historical Comparison
VNCE
RNTX

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.

About RNTX Rein Therapeutics Inc. Common Stock

Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03: a peptide for which company conducted a Phase 1b dose-ranging, placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis; LTI-01: proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment; and LTI-05 and others.

Share on Social Networks: